Case number 1:16-cv-00338
AstraZeneca LP et al v. Watson Laboratories Inc. > Summary
Court Case Number 1:16-cv-00338
Filing Date May 9, 2016
Court Delaware District Court
Status Unknown
Plaintiff
Defendant
Plaintiff Attorneys
3AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Benjamin A. Smyth
McCarter & English
Defendant Attorneys
Watson Laboratories
Attorney Name: David E. Moore
Potter Anderson & Corroon
Counter Defendant
AstraZeneca
Attorney Name: Benjamin A. Smyth
McCarter & English
Counter Claimant
Watson Laboratories
Attorney Name: David E. Moore
Potter Anderson & Corroon
Cause
35:145 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07265124 | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound | Sep 4, 2007 |
| 07250419 | Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition | Jul 31, 2007 |
| 06525060 | Triazolo(4,5-d)pyrimidine compounds | Feb 25, 2003 |
